SCHEMBL9458050

SCHEMBL9458050

C[C@]12CC[C@H]3[C@@H](CC=C4C=C(OS(=O)(=O)C(F)(F)F)CC[C@@]43C)[C@@H]1CC[C@@H]2C(N)=O

nearest known ligand 0.53

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 9/20 0.53
SRD5A1 P18405 5/20 0.53
ESR1 P03372 1/20 0.46
AR P10275 1/20 0.46
ESR2 Q92731 1/20 0.46
GRIN2D O15399 1/20 0.42
GRIN2A Q12879 1/20 0.42
GRIN2B Q13224 1/20 0.42
GRIN2C Q14957 1/20 0.42
CYP46A1 Q9Y6A2 1/20 0.42
CYP3A4 P08684 1/20 0.42
HSD17B10 Q99714 1/20 0.42
LMNA P02545 1/20 0.42
THRB P10828 1/20 0.42
PMP22 Q01453 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8904714 0.93 SRD5A2 (0.54) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8903671 0.93 SRD5A2 (0.54) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL9458401 0.88 SRD5A2 (0.50) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL9458059 0.88 SRD5A2 (0.50) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8994156 0.87 SRD5A2 (0.56) SRD5A2SRD5A1
SCHEMBL9457944 0.87 SRD5A2 (0.53) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8994119 0.87 SRD5A2 (0.49) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8994167 0.87 SRD5A2 (0.61) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8994154 0.87 SRD5A2 (0.53) SRD5A2SRD5A1ESR1ARESR2
SCHEMBL8994117 0.87 SRD5A2 (0.55) SRD5A2SRD5A1ESR1ARESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5196411-A 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors MERCK & CO., INC. (US) 1993-03-23 US disclosed
EP-0528485-A1 17Beta-acyl-3-androsta-3,5-dienes as testosterone 5alpha-reductase inhibitors MERCK & CO. INC. (US) 1993-02-24 EP disclosed
EP-0465123-A2 New intermediates in the synthesis of 17beta-acyl-3-carboxy-androsta-3,5-dienes MERCK & CO. INC. (US) 1992-01-08 EP disclosed
US-5075450-A Intermediates in the synthesis of 17β-acyl-3-carboxy-androsta-3,5-dienes MERCK & CO., INC. (US) 1991-12-24 US disclosed